Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins. - Wikidata - awgldk - TriplyDB

Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins.

Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins.

http://www.wikidata.org/entity/Q34522097

about

Resolution-associated molecular patterns (RAMP): RAMParts defending immunological homeostasis?Addressing the Global Burden of Trauma in Major Surgery Addressing the Complications of Ebola and Other Viral Hemorrhagic Fever Infections: Using Insights from Bacterial and Fungal Sepsis Wound repair: role of immune-epithelial interactions Resolution of inflammation in asthma Lipidomic profiling of bioactive lipids by mass spectrometry during microbial infections Neutrophils and inflammatory resolution in the mucosa Host modulation therapy: An indispensable part of perioceutics Periodontal disease immunology: 'double indemnity' in protecting the host Factors influencing the eicosanoids synthesis in vivo Roles of resolvins in the resolution of acute inflammation Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions Functional Metabolomics Reveals Novel Active Products in the DHA Metabolome Endogenous modulators of inflammatory cell recruitment 12- and 15-lipoxygenases in adipose tissue inflammation A metabolomic analysis of two intravenous lipid emulsions in a murine model Metabonomics reveals drastic changes in anti-inflammatory/pro-resolving polyunsaturated fatty acids-derived lipid mediators in leprosy disease Emerging targets in lipid-based therapy The immunology of stroke: from mechanisms to translation Phenotypic modulation of macrophages in response to plaque lipids.Resolvin E2 formation and impact in inflammation resolution.The neuron-astrocyte-microglia triad in a rat model of chronic cerebral hypoperfusion: protective effect of dipyridamole.Deciphering the role of n-3 polyunsaturated fatty acid-derived lipid mediators in health and disease.Proresolving lipid mediators and diabetic wound healing n-3 and n-6 Fatty acids are independently associated with lipoprotein-associated phospholipase A2 in the Multi-Ethnic Study of Atherosclerosis.Short-term physical inactivity impairs vascular function.Innate inflammatory responses in stroke: mechanisms and potential therapeutic targets.Docosahexaenoic Acid and Periodontitis in Adults: A Randomized Controlled Trial.Use of aspirin, non-steroidal anti-inflammatory drugs, and acetaminophen (paracetamol), and risk of psoriasis and psoriatic arthritis: a cohort study Erythrocyte saturated fatty acids and systemic inflammation in adults Novel n-3 immunoresolvents: structures and actions Resolvin D2 Enhances Postischemic Revascularization While Resolving Inflammation.Protective role of acetylsalicylic acid in experimental Trypanosoma cruzi infection: evidence of a 15-epi-lipoxin A₄-mediated effect.Neurogenesis and inflammation after ischemic stroke: what is known and where we go from here.Differential gene expression in thrombomodulin (TM; CD141)(+) and TM(-) dendritic cell subsets Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice.Lipoxin A4 mediates aortic contraction via RHOA/RHO kinase, endothelial dysfunction and reactive oxygen species Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution.Anti-inflammatory properties of a dried fermentate in vitro and in vivo.Chiral lipidomics of E-series resolvins: aspirin and the biosynthesis of novel mediators.

P2860

Q24597633-1207F1A5-870C-475F-BAAD-034A99D6EF83 Q26782817-7DF95A66-333B-42BD-8A8B-17DDEA3CAEBB Q26783097-562A7D0A-EA7F-4142-92CF-8824E57E25AD Q26801818-F9CDA9D9-0755-414A-B301-ED4A157DE032 Q26823724-E5E84860-8BEF-4FD7-A1BF-E90EDEE7A584 Q26825122-29674110-FB5F-4D43-869B-0F9BDBFB419E Q26827177-D9BC969B-49D0-48E2-9B0D-C7D75352BBA2 Q26852306-A67A73AB-1B0C-4D2B-8F3C-2EDCDB7596D5 Q27025438-D33F409D-F75B-4D30-91B3-B75273B81DA7 Q28083767-E35476A7-5616-472F-BBB6-24FD55D0C1DE Q28244502-B1ECF5A1-24CE-406D-AFA6-62D817574982 Q28264433-B29702D5-DE61-489E-980A-7EA9E084D0F8 Q28266178-06F4E0AD-0234-41B0-85CD-6E54439BD6E9 Q28274305-533B87E7-B90D-4973-A4C2-D8A539190C25 Q28274315-F438870D-C0C5-45CE-B14A-D5533054813C Q28485918-1AB0FA61-6811-4206-9ECD-32D4A585C1D8 Q28535353-E67A7E5A-BFA5-45C4-80AA-1A87F1769FCC Q28655456-0AE060A6-E29D-4529-8C10-72EC50D1FAF1 Q29620066-C1D3402E-8BF7-4947-BFDD-02D470C12214 Q30413906-621AAFA4-C965-4163-A3C8-799C5B886459 Q30513627-9DC629F8-3090-4CAB-AD34-D910676AE007 Q30602337-F75D7258-7B22-40EF-9CD7-92AB140BEB63 Q33631285-3F84C2F4-5BAD-491B-83E4-3F1293881BA9 Q33683848-8466703D-7505-4AD4-94DC-B84C304F16A4 Q33766630-2CA82FC9-8775-42FD-8728-AA2DD7C65A97 Q33896015-156CBC28-2467-4795-BD7B-E2C7E31B1FDB Q33925611-54A6F946-4B31-4FD0-961D-5B2B53116055 Q34019147-E69C868A-B1D2-454E-A8E4-D70B2F047DF7 Q34283073-26B4D601-4BB8-476B-A56A-3C28E7532FDD Q34289550-2B86CEF4-7724-49CE-81AA-91777150CA9F Q34348692-A46C3E19-A6F4-49AA-970F-4A7901BBC965 Q34536887-E57A498E-5789-4798-8309-BCF53971505E Q34702419-98E230D3-28B5-4BA4-B2AA-5A730DD1E6B1 Q34727139-D4D707C8-0D88-4FC8-A036-17F89534747D Q34979529-0543E27A-83D7-4E87-8057-E9DC29B16936 Q35043902-FFEFA48D-671D-41BA-9E2D-1F3A939B256A Q35068536-5D1D7D82-724F-4EED-855B-28F9AD471019 Q35098090-97E5798E-56D7-4D8B-B655-09E077C409B7 Q35149957-C4568251-52AE-4008-AB89-B94D030352B5 Q35491078-D77898E2-E772-459E-8F7F-06E5CB9025E9

P2860

Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins.

http://www.wikidata.org/entity/Q34522097

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Novel lipid mediators promote ...... impact of aspirin and statins.

@ast

Novel lipid mediators promote ...... impact of aspirin and statins.

@en

Novel lipid mediators promote ...... impact of aspirin and statins.

@nl

type

label

Novel lipid mediators promote ...... impact of aspirin and statins.

@ast

Novel lipid mediators promote ...... impact of aspirin and statins.

@en

Novel lipid mediators promote ...... impact of aspirin and statins.

@nl

prefLabel

Novel lipid mediators promote ...... impact of aspirin and statins.

@ast

Novel lipid mediators promote ...... impact of aspirin and statins.

@en

Novel lipid mediators promote ...... impact of aspirin and statins.

@nl

P1433

Q34522097-4E3451BD-F7CA-44D6-9BA7-4848390E4F20

P1476

Q34522097-1B9EF4D4-76AF-4DB6-902C-A7CBCE6C4BB7

P2093

Q34522097-0F538707-5CC0-4E48-A8F9-DE1CB9E04AAD

Q34522097-AF4210F5-A3BA-4DA3-A92C-F92B626F5D2C

P2860

Q34522097-05196572-9B8D-408B-BBC0-ED45B500B598

Q34522097-05ADDA60-3CD3-4E32-BE91-937023C2E748

Q34522097-0B0BE47F-D3EC-4FA9-9903-1DF23386C85B

Q34522097-0C5D87F4-996A-4FAA-8F5F-5C468857A0E7

Q34522097-10049498-A28F-4BA6-B979-7D95FC01E519

Q34522097-1018CA38-5000-4D64-8212-55A1C475CD2B

Q34522097-125D5CB7-BA20-46A7-A709-AE268DF3CEE5

Q34522097-12EDA6AB-55A6-4923-B41D-9A04E5FAC02D

Q34522097-18A40BB8-FDDA-4463-9A76-1A9FC4976336

Q34522097-1AAF0544-1FAF-44CF-9080-20D578410524

P304

Q34522097-8B3843C1-F07B-4C6E-94FB-4A8861D0A30A

P31

Q34522097-2D9EEC0F-8590-4524-AEB8-1B9C75B092B9

P356

Q34522097-470EF0FC-3952-4E4B-A2BB-9004A5EBED9F

P433

Q34522097-D47D1BA5-12F6-457D-9372-12729A33D2BA

P478

Q34522097-AB549914-EC1F-4C17-B081-D6BC2C90C500

P577

Q34522097-DA79C83D-BF67-4F40-88A7-613BB8129679

P5875

Q34522097-7C8E2130-B138-4887-8A5E-8DEFEEBA6549

P698

Q34522097-E252F1B1-D393-47EA-AEC0-F067FFD6F75F

P921

Q34522097-571F6FEF-1E23-4A59-9333-CEC77241C086

Q34522097-B7A73FFE-1C51-4B0B-A550-1BC47F60E968

P932

Q34522097-511BC794-665F-4451-B548-E249DDE6D3F2

P356

CIRCRESAHA.110.223883

P1433

Circulation Research

P1476

Novel lipid mediators promote ...... impact of aspirin and statins.

@en

P2093

Charles N Serhan

http://www.w3.org/2001/XMLSchema#string

Matthew Spite

http://www.w3.org/2001/XMLSchema#string

P2860

Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1

Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress

Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions

Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions

15-epi-lipoxin A4-mediated induction of nitric oxide explains how aspirin inhibits acute inflammation

Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions

International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family

Synthetic chemerin-derived peptides suppress inflammation through ChemR23

Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals

Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses

P304

1170-1184

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCRESAHA.110.223883

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P577

2010-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47755655

http://www.w3.org/2001/XMLSchema#string

P698

21071715

http://www.w3.org/2001/XMLSchema#string

P921

17-epi-resolvin D2

P932

3027152

http://www.w3.org/2001/XMLSchema#string